When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Seagate Technology (STX) stock has decreased by 12.6% in 5 trading days. Do you already hold the stock or are you considering purchasing it?

PayPal (PYPL) stock demonstrates stronger revenue growth during crucial periods, higher profitability, and a generally lower valuation compared to Block (XYZ) stock, implying that investing in PYPL might be a more advantageous choice.

Fair Isaac (FICO) stock has plummeted 9.8% in a single day. Are you an existing shareholder or considering making a purchase?

NEW YORK, NY / ACCESS Newswire / October 9, 2025 / It started quietly - a few headlines, a few countries, a few brands trying to track what happens after a product's life ends. But behind those headlines, a much larger story has been taking shape.

No matter who emerges as the winner, be it NVDA, AMD, or AVGO, TSMC remains the ultimate winner thanks to its indispensable nature as the world's leading foundry. Thanks to the numerous billion dollar deals, I believe that TSM remains well positioned to deliver high growth, profitable prospects, significantly aided by the growing global capacities. This is especially since TSM's higher capacity utilization has already well balanced the lower margin overseas fabs, with it likely to balance the tariff risks from Q3 '25 onwards as well.

ASML Holding N.V. stands out as the sole supplier of EUV lithography machines, granting it dominance in advanced semiconductor manufacturing equipment. AI-driven demand and global government support are fueling robust, long-term growth across the semiconductor industry, benefiting ASML's recurring revenue model. Despite cyclical risks and geopolitical tensions, ASML's dominant position and high barriers to entry provide pricing power and stability relative to peers.

Novo Nordisk A/S (NVO) M&A Call October 9, 2025 8:00 AM EDT Company Participants Jacob Martin Rode - Head of Investor Relations Maziar Doustdar - President, CEO & Member of the Management Board Ludovic Helfgott - Executive VP of Product & Portfolio Strategy and Member of Management Board Martin Lange - EVP of R&D, CSO and Member of the Management Board Conference Call Participants Harry Sephton - UBS Investment Bank, Research Division Simon Baker - Rothschild & Co Redburn, Research Division Peter Verdult - BNP Paribas Exane, Research Division Conor MacKay - BMO Capital Markets Equity Research Michael Nedelcovych - …

VNCE's gross margin surges to 50.4% in the fiscal second quarter, showcasing sharp pricing discipline and cost control amid tariff and freight headwinds.

Intellia Therapeutics (NTLA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Occidental Petroleum's $9.7 billion sale of OxyChem was punished by the market for several reasons. The company is paying off $6.5 billion in debt, along with additional cash saved, which it can use for returns. Overall, the company will be able to maintain its dividend, and repurchase shares, while saving to repurchase preferred equity.

Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to add its promising experimental liver disease drug, in the first major deal by the Danish drugmaker's new CEO to boost growth.

Mission Produce and Adecoagro showcase contrasting growth paths, AVO through vertical integration and AGRO through diversified agribusiness strength.

St. Petersburg, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Raymond James (NYSE: RJF) recently welcomed five financial advisors with The Manning Companies (TMC) in San Diego to Raymond James Financial Services (RJFS) – the firm's independent advisor channel – according to Casey McGee, Western assistant division director for RJFS.